The effect of Paracetamol exposure on hepatic and renal tissues during statin usage
dc.contributor.author | Aksun S. | |
dc.contributor.author | Gökcimen A. | |
dc.contributor.author | Kahyaoglu F. | |
dc.contributor.author | Demirci B. | |
dc.date.accessioned | 2024-07-22T08:09:12Z | |
dc.date.available | 2024-07-22T08:09:12Z | |
dc.date.issued | 2019 | |
dc.description.abstract | Objective: Statins and Paracetamol have widespread use in clinic and both drugs possess similar side effects; therefore, we investigated if drug-interaction occurs when the combination of these two drugs is used during therapy. Materials and methods: A total of 32 (12-15 months old) grown-up male rats were divided into four groups: Control group, RSV group (10 mg/kg Rosuvastatin/daily), APAP group (50 mg/kg Paracetamol/5 days/weekly), RSV + APAP (10 mg/kg Rosuvastatin/daily + 50 mg/kg Paracetamol/5 days/weekly). At the end of 8 weeks of chronic treatment, the blood and tissue samples were taken under the Ketamine and Xylasine anesthesia (50 mg/kg and 5 mg/kg, respectively). Results: In the liver, sinusoidal dilatations, pyknotic nuclei and hemorrhagic foci are more frequently seen in the group receiving combination therapy; although serum liver functions among groups were not significantly different. Kidney histopathologic alterations in APAP and RSV + APAP groups were found more distinct than in RSV alone group. Inducible nitric oxide synthase activity was highly increased with combination therapy in liver and kidney tissues. Conclusion: RSV-Paracetamol interaction may occur as an important drug interaction histopathologically even before it is manifested biochemically in the clinic. © 2019 De Gruyter. All rights reserved. | |
dc.identifier.DOI-ID | 10.1515/tjb-2018-0252 | |
dc.identifier.issn | 02504685 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/14727 | |
dc.language.iso | English | |
dc.publisher | De Gruyter | |
dc.rights | All Open Access; Gold Open Access | |
dc.subject | albumin | |
dc.subject | inducible nitric oxide synthase | |
dc.subject | nitric oxide | |
dc.subject | paracetamol | |
dc.subject | rosuvastatin | |
dc.subject | urea | |
dc.subject | adult | |
dc.subject | animal experiment | |
dc.subject | animal tissue | |
dc.subject | Article | |
dc.subject | cell structure | |
dc.subject | colorimetry | |
dc.subject | controlled study | |
dc.subject | drug exposure | |
dc.subject | enzyme activity | |
dc.subject | enzyme linked immunosorbent assay | |
dc.subject | histopathology | |
dc.subject | immunohistochemistry | |
dc.subject | kidney function | |
dc.subject | kidney hemorrhage | |
dc.subject | liver function | |
dc.subject | liver necrosis | |
dc.subject | male | |
dc.subject | nonhuman | |
dc.subject | rat | |
dc.subject | tissue degeneration | |
dc.title | The effect of Paracetamol exposure on hepatic and renal tissues during statin usage | |
dc.type | Article |